Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Plos One|July 5, 2012
NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancerFoluso O Ademuyiwa, Wiam Bshara, Kristopher Attwood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinomaMin-Han Tan, Carl Morrison, Pengfei Wang, et al.
Molecular Cancer|March 11, 2018
Loss of miR-204 expression is a key event in melanomaMarco Galasso, Carl Morrison, Linda Minotti, et al.
The Journal of Molecular Diagnostics : JMD|October 25, 2017
Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid TumorsJeffrey M Conroy, Sarabjot Pabla, Sean T Glenn, et al.
Pharmaceutics|October 23, 2020
Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed NanotherapeuticWalid Kamoun, Elden Swindell, Christine Pien, et al.
Journal for Immunotherapy of Cancer|August 21, 2023
T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapyBettzy Stephen, Joud Hajjar, Shrutii Sarda, et al.
Oncotarget|May 5, 2016
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulationJianmin Wang, Antonios Papanicolau-Sengos, Sreenivasulu Chintala, et al.
Pageof 12